Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
Montravers F, Kerrou K, Nataf V, Huchet V, Lotz JP, Ruszniewski P, Rougier P, Duron F, Bouchard P, Grangé JD, Houry S, Talbot JN. Montravers F, et al. Among authors: nataf v. J Clin Endocrinol Metab. 2009 Apr;94(4):1295-301. doi: 10.1210/jc.2008-1349. Epub 2009 Jan 13. J Clin Endocrinol Metab. 2009. PMID: 19141589
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Talbot JN, Fartoux L, Balogova S, Nataf V, Kerrou K, Gutman F, Huchet V, Ancel D, Grange JD, Rosmorduc O. Talbot JN, et al. Among authors: nataf v. J Nucl Med. 2010 Nov;51(11):1699-706. doi: 10.2967/jnumed.110.075507. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956466 Free article. Clinical Trial.
Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
Ohnona J, Michaud L, Balogova S, Paycha F, Nataf V, Chauchat P, Talbot JN, Kerrou K. Ohnona J, et al. Among authors: nataf v. Nucl Med Commun. 2013 May;34(5):417-25. doi: 10.1097/MNM.0b013e32835fcd9d. Nucl Med Commun. 2013. PMID: 23470463 Clinical Trial.
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T, Balogova S, Nataf V, Calzada M, Huchet V, Kerrou K, Devaux JY, Mohty M, Talbot JN, Garderet L. Cassou-Mounat T, et al. Among authors: nataf v. Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1995-2004. doi: 10.1007/s00259-016-3392-7. Epub 2016 Apr 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 27121691
18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
Gillebert Q, Huchet V, Rousseau C, Cochet A, Olivier P, Courbon F, Gontier E, Nataf V, Balogova S, Talbot JN; other ICHOROPRO investigators. Gillebert Q, et al. Among authors: nataf v. PLoS One. 2018 Feb 9;13(2):e0191487. doi: 10.1371/journal.pone.0191487. eCollection 2018. PLoS One. 2018. PMID: 29425221 Free PMC article.
Strengths and limitations of using 18fluorine-fluorodihydroxyphenylalanine PET/CT for congenital hyperinsulinism.
Montravers F, Arnoux JB, Ribeiro MJ, Kerrou K, Nataf V, Galmiche L, Aigrain Y, Bellanné-Chantelot C, Saint-Martin C, Ohnona J, Balogova S, Huchet V, Michaud L, Talbot JN, de Lonlay P. Montravers F, et al. Among authors: nataf v. Expert Rev Endocrinol Metab. 2014 Sep;9(5):477-485. doi: 10.1586/17446651.2014.949240. Epub 2014 Aug 13. Expert Rev Endocrinol Metab. 2014. PMID: 30736210
57 results